The Ionic Channel TMEM176B Inhibits the NLRP3 Inflammasome(A) Representative dot plots and absolute number of neutrophils (CD11b+ Ly6Cint Ly6G+) in peritoneal lavage 4 h after intraperitoneal (i.p.) injection with vehicle control (PBS) or 20 mg/kg ATP. In the plots, CD11b+ cells were analyzed for...
more
The Ionic Channel TMEM176B Inhibits the NLRP3 Inflammasome(A) Representative dot plots and absolute number of neutrophils (CD11b+ Ly6Cint Ly6G+) in peritoneal lavage 4 h after intraperitoneal (i.p.) injection with vehicle control (PBS) or 20 mg/kg ATP. In the plots, CD11b+ cells were analyzed for Ly6C and Ly6G expression. At least six animals were studied in each group in two independent experiments. ns, not significant; ∗p < 0.05; one-way ANOVA test.(B and C) Dose-response (B) and time-response (C) analysis of WT and Tmem176b−/− bone marrow-derived DCs (BMDCs) treated with LPS (0.25 μg/mL) for 4 h, washed and treated with ATP (left) or nigericine (Nig) (right). IL-1β in culture supernatants was determined by ELISA. One experiment representative of five is shown. ∗p < 0.05, ∗∗p < 0.01; two-way ANOVA test.(D) Western blot analysis of pro-IL-1β and pro-caspase-1 (lysates) or IL-1β and caspase-1 (supernatants) in WT and Tmem176b−/− BMDCs stimulated with LPS as in (B and C) and then treated for 90 min with 2.5 μM Nig or 0.5 mM ATP. One experiment representative of three is shown.(E) Caspase-1 activation in WT and Tmem176b−/− BMDCs treated with LPS and then exposed to 0.5 mM ATP or 2.5 μM Nig for 45 min. Cells were harvested and stained with FLICA1 reagent. One experiment representative of three is shown. ∗p < 0.05; two-way ANOVA test.(F) IL-1β secretion by WT and Tmem176b−/− BMDCs treated as in (E) compared with those treated with 10 μM Z-WEHD-FMK 15 min before ATP. One experiment representative of three is shown. ∗∗p < 0.01, ∗∗∗∗p < 0.0001; two-way ANOVA test.(G and H) Determination of IL-1β (G) and IL-18 (H) by ELISA in culture supernatants from WT, Tmem176b−/−, and Tmem176b−/−Casp1−/− BMDCs treated as in (E). One experiment representative of two is shown. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗∗p < 0.0001; two-way ANOVA test.(I) Determination of IL-1β in culture supernatants of THP-1-differentiated macrophages expressing GFP or GFP-TMEM176B untreated or treated for 3 h with 0.25 μg/mL LPS and then for 2 h with 2.5 μM Nig. One experiment representative of four is shown. ∗∗p < 0.01, ∗∗∗p < 0.001; two-way ANOVA test.(J) Calcium determination in WT and Tmem176b−/− BMDCs treated for 3 h with 0.25 μg/mL LPS and 0.5 mM ATP. Cells were loaded with Ca2+-sensitive probe Fura-2. Emission at 340/380 nm was recorded in time-lapse experiments; 0.5 mM ATP was added when indicated by the arrow. Scale bars, 10 μm.(K) Determination of IL-1β in BMDCs exposed to the NLRP3 inflammasome activator ATP as described in (E) in the presence or absence of the intracellular Ca2+ chelator BAPTA (100 μM) or DMSO vehicle control. One experiment representative of three is shown. ∗p < 0.05; two-way ANOVA test.(L) Determination of IL-1β in BMDCs following inflammasome activation in the presence of control buffer (5 mM) or high K+ buffer (120 mM). One experiment representative of three is shown. ∗p < 0.05; two-way ANOVA test.(M and N) Determination of IL-1β in BMDCs following inflammasome activation in the presence or absence of the Ca2+-activated K+ channels blockers iberiotoxin (IbTx) in (M) or hydroxychloroquine (HCQ) in (N). One experiment representative of three is shown in each case. ∗p < 0.05, ∗∗p < 0.01; two-way ANOVA test.In ELISA experiments, ND stands for not detected.Mean ± SD are shown.See also Figure S1.
less